Background Rates of weight normalization and obesity remission after Roux-en-Y gastric bypass (GB) are unknown. This study evaluated weight loss, rates of achieving body mass index (BMI) <25 or 30 kg/m 2 , recidivism, and predictors of success following GB. Methods We retrospectively studied weight and BMI at baseline, 2 and 6 months, and annually at 1-7 years in 219 patients undergoing GB at the University of Michigan from January 
, recidivism, and predictors of success following GB. Methods We retrospectively studied weight and BMI at baseline, 2 and 6 months, and annually at 1-7 years in 219 patients undergoing GB at the University of Michigan from January with significant health benefits, our results still underscore the need to address obesity with intensive clinical attention earlier in its course.
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Introduction/Purpose
Obesity afflicts tens of millions of Americans and the number of Americans with morbid obesity and number of global citizens who are overweight or obese are still on the rise [1, 2] . A recent study demonstrated the low likelihood of a patient with morbid obesity achieving normal weight, defined as body mass index (BMI) less than 25 kg/m 2 , with medical therapy with a reported annual probability of 1 in 1290 for males and 1 in 677 for females with baseline BMI 40-45 kg/m 2 [3] . A 2014 systematic review of primary case based interventions for weight loss showed a mean weight loss of only 1.36 kg at 12 months and 1.23 kg at 24 months [4] . Specialized weight management programs have demonstrated significantly greater weight loss, for example, with a very low calorie diet or meal replacement approach [5, 6] . However, head-to-head comparisons of medical weight loss approaches with weight loss surgery by randomized controlled trials have consistently favored a surgical approach for greater weight loss [7] [8] [9] [10] [11] [12] [13] . Some of these studies were limited by short-term follow-up of 1 year, weight loss being a secondary outcome, or having relatively low weight loss in the medical group compared to results achieved in other studies of medical weight management programs. Nonetheless, all are well-designed studies that showed a significantly greater weight loss with surgical intervention including two studies with 5-year follow-up [11, 13] . While there are many published series just demonstrating the excess of weight loss, no known studies in the literature report rates of weight normalization following weight loss surgery.
Given this paucity of data and to provide some degree of comparison to medical weight loss for patients interested in achieving milestone weights, we investigated the likelihood of achieving normal body mass index in a cohort of patients undergoing Roux-en-Y gastric bypass. Other variables assessed included significant weight regain of either 50 or 100% of weight lost at 2 years and percent total body weight loss at 1-7 years. Given the low number of patients achieving BMI <25 kg/m 2 , we also investigated the likelihood of obesity remission (achieving BMI <30 kg/m 2 ), rates of relapse to BMI >30 kg/m 2 , and characteristics of patients achieving a non-obese state compared with patients who remain with BMI >30 kg/m 2 . The relevance of achieving BMI targets of either 25 or 30 kg/m 2 is highlighted by a recent systematic review demonstrating an increase in mortality as BMI increases above 20-25 kg/m 2 with further increases as BMI rises [14] .
Methods
All patients over 17 years of age undergoing laparoscopic Roux-en-Y gastric bypass (GB) for obesity at the University of Michigan between January 2008 and November 2010 were included in our retrospective study. We have previously described our cohort MI-BaSiC [15] . All patients had either BMI >40 kg/m 2 or BMI >35 kg/m 2 with an obesity-related comorbidity and had previously been unsuccessful with medical treatment for obesity, consistent with Medicare and Medicaid requirements for insurance coverage of bariatric surgery. Exclusion criteria included previous bariatric surgery or the inability to complete the surgery related to unexpected operative finding. We identified 219 patients (183 female) who met these criteria and were included for analysis.
Data Collection
The University of Michigan Adult Bariatric Surgery Program is a multidisciplinary approach to weight loss [16] . Patients presenting for evaluation for bariatric surgery first undergo rigorous medical, dietary, and psychological evaluation. After surgery, patients follow up with the surgeon and the dieticians at 2 weeks and at 2 months postoperatively. Subsequent follow-up is with the endocrinologist and the dietician at the Post-Bariatric Endocrine Clinic housed in the Metabolism, Endocrinology and Diabetes Division of the Department of Medicine, where patients are asked to present at 6 and 12 months postoperatively and annually thereafter to be evaluated and treated for long-term bariatric-related complications (e.g., vitamin deficiencies and post-bariatric hypoglycemia), weight regain, and obesity-related comorbidities.
Retrospective electronic medical record review was performed, and data were abstracted from visits that occurred preoperatively (within 60 days prior to surgery) and postoperatively at 1 year ±2 months, 2 years ±3 months, 3 years ± 6 months, 4 years ± 6 months, 5 years ± 6 months, 6 years ±6 months, and 7 years ± 6 months. The last eligible visit was determined by the absolute difference between the date of data abstraction and date of surgery; for example, if a patient was 5 years and 364 days out from surgery, 5 years was the last eligible data point. Baseline demographic characteristics included sex and age. Data collected at baseline and follow-up, when available, included weight, height, and body mass index (BMI). Blood pressure was also assessed at each visit.
Statistical Analysis Percent excess weight loss (%EWL) was calculated by dividing total weight loss by the difference between actual body weight and ideal body weight, which is the weight at a BMI of 25 kg/m 2 for each patient. Percent total weight loss (%TWL) was calculated by dividing the change in weight by the initial weight. Rates of weight normalization and obesity remission were calculated by dividing the number of patients achieving the goal (BMI <25 or <30 kg/m 2 , respectively) by the initial number of patients (219); these are conservative estimates that assume that subjects who dropped out did not achieve the goal.
Summary statistics are presented as means and standard deviations. A two-sample t statistic and a 2 × 2 chi-square statistic were used to compare continuous and discrete outcomes between groups. Analyses were performed using SAS 9.4.
Results

Demographic Data
The total study population included 219 patients (183 females, 84%). Baseline characteristics of the study population are provided in Table 1 . Males were older and had a higher baseline weight but similar baseline BMI compared with females.
Data Availability
Data were available for 123 and 105 female patients at 2 and 5 years, respectively (67 and 57% follow-up rate) and for 22 and 18 male patients at 2 and 5 years (61 and 50% follow-up rate). For all patients, follow-up rate at 2 years was 66% (145/219) and at 5 years was 56% (123/219). Data availability is displayed by number of patients having available data at various time points in Fig. 1 and by the last available visit data point as compared to eligibility for data at various time points in Table 2 . Based on surgery date and timing of data collection, the number of patients eligible for having 6-and 7-year data availability was 161 and 64 patients, respectively, since 58 patients only completed 5 years at the time of chart review. Patients having available data at the last eligible time point were 119/219 (54.3%), which is shown in bold in Table 2 .
Achievement of Normal Weight
The number of female patients achieving a BMI of 25 kg/ m 2 or lower during the 7 years of observation was 31 (16.9%) with 5 (2.7%) of these patients reaching normal weight by year 2 and sustaining it at 5 years or longer. The latest available measurement of BMI was below 25 kg/m 2 for 15 (8.2%) female patients with the majority of these data points at 5 years or beyond. There were only two males who had a BMI of less than 25 kg/m 2 during follow-up with one subject having normal weight at 1 year and no subsequent weight measurements available and the other achieving normal weight at 4 years with no further data points. For all patients, a conservative estimate for the probability of achieving and sustaining normal weight with Roux-en-Y gastric bypass in this population, determined by the number of patients who are normal weight at 2 years and sustained at least 5 years postoperatively, is 2.3% (5/219). A more liberal estimate would be 6.8% (15/219), determined by the number of patients who are normal weight at the last available data point. Overall, 33 out of 219 The number of patients reaching BMI <30 kg/m 2 at any time during 7 years of follow-up was 103 (47.0%). The majority of patients who achieve this goal do so within the first year. Figure 2 displays the cumulative incidence of a patient achieving BMI <30 kg/m 2 at that time point or earlier, as a percentage of the total number of patients who underwent surgery. Supplemental Table 1 Table 2 shows when these 52 patients first and last reached BMI <30 kg/m 2 .
Association of Follow-Up and Weight Loss Maintenance
Patients who followed up for less than 2 years were less likely to obtain a BMI <30 kg/m 2 than patients who followed up (a) for more than 2 years but not including the final eligible visit or (b) until the final eligible visit (24.3 vs. 49.2 and 52.9%, respectively, p = 0.014 for comparison between the first two groups). Additionally, 61% of patients who achieved BMI <30 kg/m 2 followed up through the final eligible visit versus 48% of patients who did not achieve this goal (p = 0.056).
Association Between Initial BMI and Weight Loss
Initial mean BMI of females achieving BMI <30 kg/m 2 was 43.5 versus 50.4 kg/m 2 in females who did not reach this cutoff (p < 0.0001). For males, the corresponding mean initial BMIs were 44.6 and 48.1 kg/m 2 , respectively (p = 0.18). Patients who reached BMI <30 kg/m 2 had a greater difference between maximum and minimum BMI than their counterparts who did not (17.6 vs. 14.3 kg/m 2 , p < 0.0001). Figure 3 shows percent weight loss and Fig. 4 shows excess weight loss over time for patients divided into three strata based on initial BMI (lowest BMI group <43 kg/ m 2 , middle BMI group 43-48 kg/m 2 , highest BMI group >48 kg/m 2 ). The inter-group differences for %TWL were significant at all time points starting at 1 year postoperatively with greater percent total weight loss in the group with the highest baseline BMI. Conversely, greater percent excess weight loss was seen in patients with lower initial baseline BMI through 1 year postoperatively with p values at 2, 6, and 12 months of <0.0001, <0.0001, and 0.004, respectively. 
Percent Total Weight Loss Stratified by Sex and Age
Percent total weight loss for females and males is displayed in Fig. 5 . While there were no significant differences in %TWL between males and females, there was greater variability in weight loss for males. For both sexes combined, mean %TWL peaked at 1 year with 31.8% and at 5, 6, and 7 years, respectively, was 24.4, 25.0, and 23.6%. Data availability is notably low at 7 years (24 females and 4 males) but more robust prior.
Interestingly, there was a significant effect of age on the ability to reach a BMI <30 kg/m 2 ; the mean age of the subgroup who achieved BMI <30 kg/m 2 was 3 years younger at baseline at 42 ± 11 versus 45 ± 11 years (p = 0.0294).
Weight Regain
No female patients had a higher postoperative weight than their preoperative weight, while two male patients gained weight immediately postoperatively and never subsequently fell below their preoperative weight. Thirteen (7.1%) female patients regained half of the weight they lost after 2 years, all but 1 at 5 years or later. In addition to the two male patients who never lost weight, two male patients regained half of the weight they lost after 2 years (a rate of 11.2% if all four patients are counted). A general trend of weight regain can be seen after 1 year (Fig. 5) . Figure 6 shows the cumulative risk of a patient who achieved BMI <30 kg/m 2 of relapsing based on the interval between first BMI <30 kg/m 2 and first subsequent BMI >30 kg/m 2 .
Change in Blood Pressure
A significant decrease was seen for both systolic and diastolic blood pressure at all follow-up points. Maximal effect was achieved at 1 year with a mean decrease of 14 ± 7 mmHg (p < .0001). Blood pressure at 5 years remained improved with a mean decrease of 11 ± 3 mmHg (p < 0.0001) with similar changes at 6 and 7 years. There were no significant differences between sexes in regard to blood pressure. There was a slight difference in systolic blood pressure between patients who achieved BMI <30 kg/m 2 and those who did not at initial visit (135 vs. 140 mmHg, respectively, p = 0.048) as well as at the final visit (122 vs. 129 mmHg, respectively, p = 0.005). These differences may be attributable to age differences between the two groups, as a general linear model adjusted for age resulted in no residual difference in the blood pressure at baseline or during follow-up (data not shown). On the contrary, the diastolic blood pressures at baseline were comparable between those who had remission of obesity with BMI <30 kg/m 2 versus those who did not fully remit (75 ± 9 vs. 75 ± 10 mmHg respectively at baseline and 72 ± 11 vs. 72 ± 11 mmHg at the last visit). The change in diastolic blood pressure from initial to last visit was −4 ± 12 mmHg versus −4 ± 14 mmHg, which was significant within each group (p < 0.01) but was not significantly different between the two groups.
Discussion
In this study, we investigated the cumulative likelihood of achieving two important milestones after long-term followup in our cohort undergoing gastric bypass surgery. Achieving remission of obesity appears to be a more attainable outcome occurring in nearly half of the patients and being sustainable in a substantial percentage. Having a lower BMI at baseline and following up for a longer period are both associated with a higher likelihood of reaching remission of obesity.
Our observational retrospective cohort study is the first to our knowledge to directly examine rates of achieving normal weight following weight loss surgery such as laparoscopic Roux-en-Y gastric bypass. While we do not want to send the message that achieving enough weight loss to reach a BMI of 25 or 30 kg/m 2 is the ultimate goal of weight loss surgery, we investigated milestone weight loss to help guide more realistic expectations from surgical intervention. The data add to the growing body of evidence that gastric bypass provides sustainable weight loss in patients with morbid obesity. It is difficult to compare our results for weight normalization to rates reported for primary care-based medical weight loss strategies due to differences in study design and statistical methods [3] . Regardless, despite excellent weight loss in the majority of patients undergoing gastric bypass, the rate of achieving BMI <25 kg/m 2 remains low (2.3-6.8%), underscoring the challenge of weight normalization in patients with a very high initial body mass index (the mean preoperative BMI was 47.0 kg/m 2 in our study population). There has been interesting investigation done related to the metabolic adaptation that occurs following weight loss that has demonstrated patients experiencing greater than expected reductions in resting metabolic rate, suggesting one mechanism through which the body defends against weight loss and favors returning to a desired weight set point [17, 18] . However, one recent small study showed that patients undergoing GB experience no significant metabolic adaptation (only the expected decline in resting metabolic rate) whereas participants with the television show BThe Biggest Loser^who employed a medical weight loss strategy had much lower resting metabolic rates despite similar weight loss, highlighting a potential benefit for weight loss maintenance following weight loss surgery versus medical weight loss [19] .
Given the low number of patients achieving BMI <25 kg/m 2 , we also wanted to focus on another important clinical goal of obesity remission (BMI <30 kg/m 2 ). Taking into account that the mean BMI prior to surgery in our cohort was 47.1 kg/m 2 , this target is associated with significant estimated health benefits and likely brings a mortality benefit for patients undergoing GB [14, 16] . It is both noteworthy and encouraging that nearly half of the patients in the study achieved BMI <30 kg/m 2 with just over half of those patients (about one quarter of the overall sample) having BMI <30 kg/m 2 at their final weigh-in. There was no difference between sexes, although this may reflect the low number of males in the study. Initial BMI was inversely correlated to probability of achieving BMI <30 kg/m 2 . Division of patients into three strata based on BMI cutoffs showed greater percent weight loss in patients with the highest BMI beyond 1 year but greater excess weight loss in patients with lower initial baseline BMI through 1 year. There is significant heterogeneity in previous studies as to whether baseline BMI is associated with better or worse outcomes depending on whether %EWL or %TWL is used [20] , but in general, %TWL is preferred as the outcome measure in long-term studies of bariatric surgery if one wishes to reduce variability based on initial BMI [21, 22] . Our data support a conclusion that higher BMI is associated with improved long-term %TWL following GB but a lower rate of achieving BMI <30 kg/m 2 . Rates of significant weight regain (>50% of the weight lost at 2 years) at 5-7 years were encouragingly low, and fewer than 1% of patients had a weight higher than their preoperative weight at any point. Recidivism is apparent in regard to both general weight regain and in patients relapsing back to BMI >30 kg/m 2 . This has been recently evaluated systemically with potential contributing etiologies identified as psychiatric, physical inactivity, endocrinopathies/metabolic, and dietary non-compliance [23] .
Improvement in Blood Pressure
Overall, there was significant improvement in primarily systolic blood pressure whether the subjects reached a BMI of 30 kg/m 2 or not, with a clinically small, but statistically significant, difference between the final blood pressures attained in the patients who did or did not reach this threshold. Whether such a difference will ultimately affect overall cardiovascular risk remains to be seen in our cohort. Based on the recently published SPRINT trial [24] , there may be a benefit in both cardiovascular and all-cause mortality with blood pressure lowering in the average range seen in our patients. Diastolic blood pressures attained as a result of gastric bypass are significantly lower compared to baseline blood pressures regardless of the whether they reached BMI <30 kg/m 2 or not.
Attrition and Importance of Long-Term Follow-Up
Studies of bariatric surgery are known to have poor followup rates with a recent large systematic review showing a mean of 40% attrition at 1 year and even higher rates at study completion [25] , highlighting the challenges of this patient population. Our follow-up was notably better than this with 71.7% at 1 year, 54.3% of patients completing the study and data availability of over 60% at 2 years, and over 50% at 5 years. Follow-up of 2 years or greater was associated with higher likelihood of achieving BMI <30 kg/m 2 , suggesting early dropout predicts poor success, although this conclusion is limited by lack of follow-up data for these patients and it may be that more successful patients return to clinic at a higher rate.
Study Limitations and Strengths
Surgical complications are often brought up as a significant downside of weight loss surgery when comparisons to medical weight loss are entertained; previous studies report short-term complication rates of 9.5% (2.7% major) with predictive factors available to help patients assess risks and benefits of surgery [26] [27] [28] . We have previously reported the rate of surgical complications as 10.2% within 30 days of surgery with reoperation rates of 3.0% in a patient population that includes the study sample of this investigation [15] . A potential critique of this study is the question of whether patients with obesity achieving BMI <25 kg/m 2 reflect malnutrition rather than success. Malnutrition following gastric bypass is uncommon in clinical practice, although rates are difficult to estimate definitively due to lack of studies with very long-term follow-up and no clear definition [29] . While two patients in our study had BMI <18.5 kg/m 2 at any point, this does not necessarily correlate with malnutrition which can occur at high or low body mass index and requires clinical evaluation. While albumin is a poor marker of nutritional status [30] , we did evaluate this in patients with BMI <25 kg/m 2 , and only one patient had a sustained albumin level <3.5 g/dL. This patient was also felt clinically to have malnutrition and underwent reversal of GB due to gastroesophageal ulcer and stenosis felt to be attributable to smoking. Other study limitations include the retrospective study design which may introduce selection or other bias, incomplete data availability which may favor follow-up of patients who are doing well or poorly, and patient selection from a single tertiary care referral center which may limit generalizability. Strengths of the study include large sample size, sequential patient inclusion which makes the results more generalizable to all patients in comparison to the more stringent requirements for RCTs, and long-term follow up of 5-7 years.
Conclusion
A modest proportion of patients undergoing gastric bypass achieve normal body weight; however, almost half of patients achieve reversal of obesity with BMI <30 kg/m 2 with 5-7 years of follow-up in a population with mean preoperative BMI of 47.0 kg/m 2 likely affording significant metabolic and possibly mortality benefit. Preoperative BMI was correlated with greater total weight loss but negatively associated with achievement of BMI <30 kg/m 2 . Longer follow-up time was positively associated with reaching BMI <30 kg/m 2 . Realistic goals should be set for patients undergoing gastric bypass, in light of the baseline BMI. Recidivism is seen in this and other studies highlighting the body's natural defense of current weight [19, 23] . Given the inherent difficulty of achieving normal weight, interventions targeting weight loss prior to reaching the greater stages of obesity are needed. It should be a public health urgency for the USA and other developed countries to make this a priority especially for young adults with BMI levels >30 kg/m 2 . We should also carefully examine the option of pursuing surgery at lower BMI cutoffs at which point patients have a greater likelihood of obesity remission. Further studies with larger numbers are needed to more comprehensively delineate whether weight normalization or obesity remission are more feasible goals for specific subgroups of patients, to explore an approach to patients who are lost to follow-up, and to examine the benefit of bariatric surgery at lower preoperative BMI to optimize weight loss success.
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